Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab

Authors:

Abstract
No abstract available

This publication has 26 references indexed in Scilit: